News by Tag: Indian Antibodies Market
Evaluate Strategies to Launch Monoclonal Antibodies in India
June 26, 2012
IMARC Group's new report will enable you to gain a comprehensive understanding of the Indian diagnostic and therapeutic antibodies market
June 26, 2012
IMARC Group's new report will enable you to gain a comprehensive understanding of the Indian diagnostic and therapeutic antibodies market
Indian Immunodiagnostics Market to Grow at a CAGR of 11% in the Next Five Years
February 8, 2012
Driven by factors such as increasing popularity in preliminary testing, portability and ease of use; the market for Immunodiagnostics is expected to grow robustly in the coming years.
February 8, 2012
Driven by factors such as increasing popularity in preliminary testing, portability and ease of use; the market for Immunodiagnostics is expected to grow robustly in the coming years.
Most of the Marketed Monoclonal Antibodies Lack a Patent Protection in India
January 25, 2012
Biosimilar manufacturers are currently free to copy and manufacture most of the globally marketed therapeutic monoclonal antibodies in India.
January 25, 2012
Biosimilar manufacturers are currently free to copy and manufacture most of the globally marketed therapeutic monoclonal antibodies in India.
IMARC Releases the Most Robust Analysis on the Indian Diagnostic & Therapeutic Antibodies Market
January 19, 2012
A new report from IMARC Group finds that the Indian market for both diagnostic and therapeutic antibodies is expected to grow exponentially in the coming years.
January 19, 2012
A new report from IMARC Group finds that the Indian market for both diagnostic and therapeutic antibodies is expected to grow exponentially in the coming years.